Mitchell Labiak
Mitchell Labiak is a business reporter known for covering significant developments in the financial and corporate sectors, particularly within the pharmaceutical industry. Recently, he reported on AstraZeneca's decision to pause its planned £200 million investment in a Cambridge research site, which was expected to create 1,000 jobs, highlighting the broader implications for the UK pharmaceutical market.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Mitchell Labiak is a business reporter.
5